G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
4.090
-0.130 (-3.08%)
At close: May 24, 2024, 4:00 PM
4.100
+0.010 (0.24%)
After-hours: May 24, 2024, 6:45 PM EDT

G1 Therapeutics Revenue

G1 Therapeutics had revenue of $84.04M in the twelve months ending March 31, 2024, with 46.55% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $14.48M with 11.82% year-over-year growth. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.

Revenue (ttm)
$84.04M
Revenue Growth
+46.55%
P/S Ratio
2.54
Revenue / Employee
$840,410
Employees
100
Market Cap
213.83M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202382.51M31.21M60.84%
Dec 31, 202251.30M19.83M62.98%
Dec 31, 202131.48M-13.81M-30.49%
Dec 31, 202045.29M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 2015522.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 301.87M
NeuroPace 69.07M
Butterfly Network 68.08M
Werewolf Therapeutics 16.22M
Delcath Systems 4.61M
Ovid Therapeutics 473.54K
Revenue Rankings